Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
PI3K/AKT/mTOR Inhibition in Advanced BC: Is There Any Benefit With Alpelisib, Capivasertib, and Everolimus?
Login to view comments.
Click here to Login
8th Annual USC Multi-Disciplinary Breast Cancer Symposium